By Sriparna Roy and Bhanvi Satija (Reuters) -Shares of global vaccine makers were muted on Tuesday as investors and analysts ...

Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Click for my ...

Shares of global vaccine makers were mixed on Tuesday, as investors assessed U.S. Health Secretary Robert F. Kennedy Jr.'s ...

While the news isn’t great for vaccine manufacturers, it could have been worse. Shares of pure vaccine play Moderna rose 0.3% ...

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

Just two days after retiring the entirety of the US Centers for Disease Control and Prevention’s vaccine advisory panel, US ...

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured ...

Health and Human Services Secretary Robert F. Kennedy Jr.’s moves to upend decades of vaccine policy could hit patients hardest in their wallets, as shifting guidance over shots could make ...

A fired committee member who served on the panel since July 2024 said the decision to fire him and his colleagues came from ...

Three of the health secretary’s picks to replace fired members of an influential panel that sets U.S. vaccine policies have ...